PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

News

Posts navigation

Previous 1 2 3 … 10 Next
EMA publishes overview of medicines recommended in 2022

EMA publishes overview of medicines recommended in 2022

The European Medicines Agency (EMA) has published its key recommendations for marketing authorisations in 2022 in ‘Human Medicines Highlights 2022’.

21 Feb 2023
Read More
Thanks to our guest speaker Prof Asif Ahmed

Thanks to our guest speaker Prof Asif Ahmed

Those gathered at the annual PharmaMedic Consultancy’s social event on 16 February were treated to an engaging presentation by guest speaker Prof Asif Ahmed.

20 Feb 2023
Read More
Medical Technology Strategy launched by UK Government

Medical Technology Strategy launched by UK Government

The UK Government has published its Medical Technology Strategy policy document, designed to ensure that the health and social care system can access safe, effective and innovative medical technologies.

16 Feb 2023
Read More
Prof Asif Ahmed guest speaker at PharmaMedic Consultancy event

Prof Asif Ahmed guest speaker at PharmaMedic Consultancy event

We are looking forward to PharmaMedic Consultancy’s annual social event this Thursday evening (16 February 2023), featuring guest speaker Prof Asif Ahmed from MirZyme Therapeutics.

14 Feb 2023
Read More
UK Government publishes response to MHRA fee consultation

UK Government publishes response to MHRA fee consultation

The Government has published its response to the consultation on proposals for changes to the Medicines and Healthcare products Regulatory Agency’s (MHRA) statutory fees.

13 Feb 2023
Read More
MHRA announces new international recognition framework for MAs from 2024

MHRA announces new international recognition framework for MAs from 2024

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that the European Commission Decision Reliance Procedure (ECDRP) has been extended to 31 December 2023. After that a new international recognition framework will be instituted, from 1 January 2024.

9 Feb 2023
Read More
Join Our Free Breakfast Briefing: Quality Systems in Pharma – Who, What, When?

Join Our Free Breakfast Briefing: Quality Systems in Pharma – Who, What, When?

PharmaMedic is delighted to announce our next virtual event on Thursday 23rd February 2023 at 08am (GMT). In this briefing, we will be discussing the important area of quality systems and their importance in our day-to-day roles. Listen to the discussions then ask any questions you may have. Read on to learn more, and to register your attendance.

7 Feb 2023
Read More
UK leads on new regulatory framework for point-of-care medicine manufacturing

UK leads on new regulatory framework for point-of-care medicine manufacturing

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced the establishment of a ground-breaking regulatory framework to simplify the manufacture of innovative medicines at the point of care. The UK’s Human Medicines and Clinical Trials legislation will be amended to enable this and brought to parliament later in 2023.

6 Feb 2023
Read More
Pharma deals at 41st JP Morgan Healthcare conference

Pharma deals at 41st JP Morgan Healthcare conference

Against a backdrop of challenging circumstances around the globe in 2022, what do the pharma deals announced during the recent JP Morgan Healthcare conference suggest about investor sentiment and the way forward for pharma in 2023?

1 Feb 2023
Read More
MHRA ramps up assessment capacity for in-vitro diagnostic devices

MHRA ramps up assessment capacity for in-vitro diagnostic devices

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended the designation of UL International UK Ltd as an Approved Body.

30 Jan 2023
Read More

Posts navigation

Previous 1 2 3 … 10 Next

NewsCategories

  • General
  • Medical Affairs
  • Rare diseases

NewsTags

#ABPI #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EMA #EU #FDA #innovation #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #medtech #mentalhealth #mhra #NHS #NICE #outsourcing #pharmaregulation #pharmatrends #pre-eclampsia #R&D #raredisease #rarediseases #regulation #regulatory #UKgovernment #ukpharma #ukregulation #VPAS @PPharmamedic AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital